Pretransplant serum vitamin d levels and risk of cancer after renal transplantation

Transplantation

Volumn 85, Issue 12, 2008, Pages 1755-1759

  Ducloux, Didier ^a,b   Courivaud, Cécile ^a   Bamoulid, Jamal ^a   Kazory, Amir ^a   Dumoulin, Gilles ^c   Chalopin, Jean Marc ^a,b  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b HÔPITAL SAINT JACQUES   (France)

^c UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Cancer; Kidney transplantation; Vitamin D

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CALCIFEDIOL; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; COLON CANCER; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CANCER; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; OVARY CANCER; PANCREAS CANCER; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; SKIN CANCER; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; FOLLOW UP; INCIDENCE; KIDNEY TUMOR; LUNG TUMOR; MIDDLE AGED; NEOPLASM; POSTOPERATIVE COMPLICATION; PREDICTION AND FORECASTING; RISK FACTOR;

ADULT; BIOLOGICAL MARKERS; CALCIFEDIOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; LUNG NEOPLASMS; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 49149095924     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318172cb2c     Document Type: Article

References (22)

1. Webster AC, Craig JC, Simpson JM, et al. Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: A cohort study of 15183 recipients. Am J Transplant 2007; 7: 2140.
2. Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905.
3. Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 1995; 60: 183.
4. London NJ, Farmery SM, Will EJ, et al. Risk of neoplasia in renal transplant patients. Lancet 1995; 346: 403.
5. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005; 26: 662.
6. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004; 80: 1678S.
7. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16: 713.
8. Ahonen MH, Tankanen L, Teppo L, et al. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000; 11: 847.
9. Mawer EB, Walls J, Howell A, Davies M, et al. Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin EndocrinolMetab 1997; 82: 118.
10. Vandewalle B, Adenis A, Hornez L, et al. 1,25-Dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissues. Cancer Lett 1994; 86: 67.
11. Abe E, Miyaura C, Sakagami H. Differentiation of mouse myeloid leukemia cells induced by 1a,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 1981; 78: 4990.
12. Masuda S, Jones G. Promise of vitamin D analogues in the treatment of hyperproliferative conditions. Mol Cancer Ther 2006; 5: 797.
13. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996; 10: 142.
14. 3 in HL60 cells. Cancer Res 1996; 56:264.
15. Yang L, Yang J, Venkateswarlu S, et al. Autocrine TGF-b signalling mediates vitamin D3 analog-induced growth inhibition in breast cells. J Cell Physiol 2001; 188:383.
16. Rozen F, Yang XF, Huynh H, et al. Anti-proliferative action of vitamin D-related compounds and insulin-like growth factor-binding proten 5 accumulation. J Natl Cancer Inst 1997; 89: 652.
17. Wagner N, Wagner KD, Schley G, et al. 1α,25-dihydroxyvitamin D3-induced apoptosis of retinoblastoma cells is associated with reciprocal changes of Bcl-2 and bax. Exp Eye Res 2003; 77: 1.
18. 3-regulated gene expression by microarray analysis. J Steroid Biochem Mol Biol 2004; 89: 239.
19. 3 a potent angiogenesis inhibitor on rat mammary tumors induced by 7,12-dimethylbenzanthracene. Anticancer Drugs 1991; 2: 475.
20. Laing ME, Dicker P, Moloney FJ, et al. Association of methylenetet-rahydrofolate reductase polymorphism and the risk of squamous cell carcinoma in renal transplant patients. Transplantation 2007; 84: 113.
21. Segal E, Baruch Y, Kramsky R, et al. Vitamin D deficiency in liver transplant patients in Israel. Transpl Proc 2001; 33: 2955.
22. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842.